RxDoctor Payments Data

Robert Willard

MOHS-Micrographic Surgery · Doylestown, PANPI 1427097427

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations.

$3,509in general payments, 2019–2025

Across 194 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$690
  • Mimedx Group, Inc.$598
  • Johnson & Johnson$497
  • Regeneron Healthcare Solutions, Inc.$198
  • Sun Pharmaceutical Industries Inc.$156
  • Sanofi$140
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$3,509100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,509 in reported general payments places this provider in the 65th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.

See all mohs-micrographic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$1,429,288
Medicare patients
730
Services billed
12,269

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sumatriptan Succinate12$6,422
Clobetasol Propionate48$1,701
Doxycycline Hyclate137$1,026
Cephalexin184$673
Fluorouracil12$598
Ketoconazole36$573
Metronidazole11$353
Mupirocin43$254
Triamcinolone Acetonide26$223
Minoxidil11$87
Tramadol Hcl19$40
Amoxicillin14$20

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Doylestown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →